The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 25, 2015

Filed:

Aug. 03, 2006
Applicants:

Wei Zhang, Philadelphia, PA (US);

Michael S. Fleming, Londonderry, NH (US);

Godfrey Amphlett, Cambridge, MA (US);

Hung-wei Chih, Burlingame, CA (US);

Elizabeth Bartlett, Cambridge, MA (US);

Inventors:

Wei Zhang, Philadelphia, PA (US);

Michael S. Fleming, Londonderry, NH (US);

Godfrey Amphlett, Cambridge, MA (US);

Hung-wei Chih, Burlingame, CA (US);

Elizabeth Bartlett, Cambridge, MA (US);

Assignee:

ImmunoGen, Inc., Waltham, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 47/48 (2006.01); A61K 9/00 (2006.01); A61K 47/10 (2006.01); A61K 47/26 (2006.01); A61K 47/40 (2006.01);
U.S. Cl.
CPC ...
A61K 47/48561 (2013.01); A61K 9/0019 (2013.01); A61K 47/48384 (2013.01); A61K 47/48615 (2013.01); A61K 47/10 (2013.01); A61K 47/26 (2013.01); A61K 47/40 (2013.01);
Abstract

The present invention provides an immunoconjugate formulation that is substantially free of particles, the immunoconjugate formulation comprising: an immunoconjugate and one or more excipients selected from the group consisting of: sucrose, polysorbate 20, polysorbate 80, cyclodextrin, dextrose, glycerol, polyethylene glycol, mannitol, sodium chloride, and an amino acid, wherein the formulation is a buffered aqueous solution having a pH of 4.5 to 7.6. The present invention also provides an immunoconjugate formulation that is substantially free of aggregates, the immunoconjugate formulation comprising: an immunoconjugate and one or more excipients selected from the group consisting of histidine, sucrose, glycine and sodium chloride, wherein the formulation is a buffered aqueous solution having a pH of 4.5 to 7.6. The present invention further provides an immunoconjugate formulation that is substantially free of both particles and aggregates.


Find Patent Forward Citations

Loading…